Glomérulo esclerosis focal y segmentaria. Trasplante renal y plasmaféresis

Burgos Pratx, Leandro Daniel.
Rev. argent. transfus ; 35(1-2): 29-37, 2009. tab, graf
Artículo en Español | LILACS | ID: lil-661513

Documentos relacionados

  1. Efficacy of combined rituximab and daratumumab treatment in posttransplant recurrent focal segmental glomerulosclerosis.
  2. Stage lighting on PAR-1: a step further in the understanding of acquired focal and segmental glomerulosclerosis.
  3. Interventions for focal segmental glomerulosclerosis in adults.
  4. [Expert consensus on diagnosis and treatment of focal segmental glomerulosclerosis in adults].
  5. Post-operative recurrence of focal segmental glomerulosclerosis according to pre-transplant treatment after kidney transplantation.
  6. Post-transplant recurrence of focal segmental glomerular sclerosis: consensus statements.
  7. Inhibition of RAC attenuates Adriamycin-induced podocyte injury.
  8. Current approaches to overcome recurrent focal segmental glomerulosclerosis after kidney transplantation.
  9. STAT-3 signaling role in an experimental model of nephropathy induced by doxorubicin.
  10. Phenotype-Genotype Correlations in Three Different Cases of Adult-Onset Genetic Focal Segmental Glomerulosclerosis.